ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

639
Analysis
Health Care • South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
bearish•MSCI ACWI Index
•03 Apr 2020 10:05

Global Equities (ACWI-US) Likely to Retest the March Low

We continue to believe global equities (ACWI-US) are likely to test the recent low made on March 23, with an undercut of roughly 10% also in the...

Logo
510 Views
Share
bearish•Celltrion Inc
•02 Apr 2020 03:56

Celltrion Block Deals: Weirdest One to Date

Let's first recap on how the bankers structured these block deals. The discount is quite generous: 8~9.8% for Celltrion and 7~8.8% for Healthcare....

Logo
477 Views
Share
bullish•Celltrion Inc
•01 Apr 2020 20:13

Block Deal Sales of Celltrion & Celltrion Healthcare Stakes by ION Investments

It was reported after the market close today that GIC's investment affiliate ION Investments has put up its shares in Celltrion Inc (068270 KS) and...

Logo
514 Views
Share
bearish•Celltrion Inc
•01 Apr 2020 17:32

Celltrion+Celltrion Healthcare Placement- Discount Looks Enticing but the Deal Appears Opportunistic

Temasek plans to raise US$380m via selling 1.9% stake in Celltrion Healthcare (091990 KS) and another US$132m via selling a 1.5% stake in Celltrion...

Logo
487 Views
Share
bullish•Quantitative Analysis
•01 Apr 2020 05:39

Short Covering Continues - Celltrion Leads The Way

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 27 March 2020, the...

Logo
502 Views
Share
x